Shares of Anika Therapeutics fell during Friday's trading after the company said sales fell in one of its segments and lowered full-year guidance for that unit. Shares slipped 19.3% to $11.89 and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results